). In this family, the hydrophobic part and the linker (X) can be varied with retention of high activity. Tazarotene, an RAR-β,γ selective acetylenic retinoid, was chosen for development as a topical agent for psoriasis and acne. Am580 (RAR-α selective) has powerful and selective cyto-differentiating effects on APL. Various acidic heterocycles are classically used by medicinal chemists as carboxylic acid bioisosteres. 8 Tetrazole is a common bioisostere of the carboxylic acid group but in the particular case of retinoids led to loss of activity. 9 On the contrary, thiazolidinedione moiety has been described by Tashima et al. to be an effective replacement of the carboxylic acid ( Figure  2a) . 10, 11 More recently, bioisosteric replacement of carboxylic acid with a tropolone ring is reported (Figure 2b ). Another example of acidic heterocycle is the 1,2,4-oxadiazol-5-one ring, found in AT1 antagonists 14 , COX inhibitors 15 , PLA2 inhibitors 16 and modulators of GluR 17 . This heterocycle can replace carboxylic acids but displays geometrically different protomers and slightly different physico-chemical properties. Compounds bearing this heterocycle have different lipophilic properties that may translate into improved bioavailability compared with their carboxylic analogues. Indeed, ΔlogD 7.4 between benzoic acid and 3-phenyl-1,2,4-oxadiazol-5-one = 0.7 log unit, the oxadiazolone being more hydrophobic than its carboxylic counterpart. 18 In our project aiming at synthesizing various analogues of pharmacologically active carboxylic acids, we explored the replacement of the carboxylic acid function by the 1,2,4-oxadiazol-5-one moiety in two series of retinoids: analogues of the tazarotene, a RAR-β,γ selective acetylenic retinoid, and Am580, an RAR-α selective retinoid (Figure 3 ). First, we investigated the synthesis of tazarotenic acid analogues.
19 Precursors 1 and 2 were synthesized as previously described from the corresponding nitrile in two steps (Scheme 1). We have recently reported a strategy for solid phase synthesis of acetylenic derivatives of 3-aryl-1,2,4-oxadiazol-5-one thanks to a Sonogashira reaction.
Compound 1 was thus grafted on resin and then reacted with 6-ethynyl-1,1,4,4-tetramethyl-1,2,3,4-tetrahydro-naphthalene 3 to yield compounds 4 (Scheme 2). In the search of a more cost-effective synthesis, we also developed the first solution Sonogashira coupling with an unprotected 1,2,4-oxadiazol-5-one ring. Such strategy has been used for Suzuki-Miyaura reactions 21 and successfully applied for the synthesis of compounds 5-7 (Scheme 3). Some carboxylic acid analogues described in literature were also synthesized like compounds 8 and 9 in order to compare retinoidal activity of our oxadiazolone derivatives with known retinoic compounds. Am580 and its 1,2,4-oxadiazol-5-one analog 10 were synthesized as described in Scheme 5. The retinoidal activities of the synthesized compounds were examined in terms of potency and efficacy and results are presented in Tazarotene and its analogue 8 are RAR-β,γ selective acetylenic retinoids, whereas analogue 9 is very active on the three subtypes. Interestingly, 1,2,4-oxadiazol-5-one 4 and 5 activities differ from their carboxylic acids analogues. Indeed, compound 5 is slightly active on RAR-β. Compound 4, though nanomolar on RAR-β (EC 50 = 26 nM), is less active than 9 but displays a better selectivity on RAR-β,γ subtypes and an efficacy comparable with tazarotene. As expected, bended analogue 7 is not active since it is not linear enough to fit the RAR pharmacophore. In the second series, compound 10 is active on RAR-α with a similar efficacy to that of Am580 (40 versus 43 %). In the light of these results, both compounds 4 and 10 could be good starting points for further optimization. All these compounds were checked for cross-reactivity with the retinoid X receptor (RXR α, β, γ) and found to be inactive.
In conclusion, we have described the solid-phase or solution-phase syntheses of a new series of non carboxylic acid RAR ligands. We have shown that the 1,2,4-oxadiazol-5-one moiety can act as a bioisostere of the carboxylic acid function in retinoid structures. In particular the retinoidal activity of compound 4 (RAR-β,γ selective) is significant, considering that replacement of the carboxylic acid in retinoid structures with bioisosteric functional groups is generally ineffective. These non carboxylic acid type RAR ligands may exhibit different pharmacological behaviors from classical carboxylic acid compounds, as well as unique biological activity, and they may provide further scope for clinical applications.
